Factor VII/VIIa: a new antigen in the anti‐phospholipid antibody syndrome
Open Access
- 14 February 2003
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 120 (4), 618-626
- https://doi.org/10.1046/j.1365-2141.2003.04161.x
Abstract
Summary. We investigated antibodies to factor VII/VIIa (FVII/VIIa) and five other common target antigens in 33 patients with a history of anti‐phospholipid syndrome (APS) and 50 healthy controls using an enzyme‐linked immunosorbent assay (ELISA) technique. We found that antibody to FVII/VIIa, a previously unrecognized and common antigen in APS, was present in 67% of patients. Frequencies of antibodies to other target antigens were: anti‐beta‐2 glycoprotein 1 (anti‐β2GP1), 88%; anti‐cardiolipin (anti‐CL), 76%; anti‐phosphatidylethanolamine (anti‐PE), 67%; anti‐phosphatidylserine (anti‐PS), 64%; and anti‐phosphatidylcholine (anti‐PC), 59%. Most patients had antibodies against multiple antigens, but a few were positive for only anti‐β2GP1 (12%) or anti‐CL (3%). Positivity for anti‐FVII/VIIa was significantly associated with positivity for anti‐PE, anti‐PS and/or anti‐PC (P < 0·05) but not anti‐β2GP1. When frequencies of immunoglobulin G (IgG) versus immunoglobulin M (IgM) antibodies were compared, anti‐β2GP1 IgG correlated with the lupus anticoagulant (P < 0·05) and was significantly more prevalent than IgM, but the reverse was seen for all other antigens. In arterial thrombosis, IgM was more prevalent for all antigens, and was significantly associated with FVII/VIIa, PE and PS, whereas in venous thrombosis, IgG was frequently prevalent, especially in association with FVII/VIIa, β2GP1 and CL. In summary, FVII/VIIa is a new and common antigen in APS. Anti‐FVII/VIIa is often associated with anti‐PE, anti‐PS and anti‐PC. The IgM class is more frequently associated with arterial thrombosis and the IgG class with venous thrombosis.Keywords
This publication has 59 references indexed in Scilit:
- Tissue Factor Is Not Involved in the Mitogenic Activity of Factor VIIaBiochemical and Biophysical Research Communications, 2001
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Antiphospholipid antibodies and thrombosisThe Lancet, 1999
- Anti‐endothelial cell antibodies in primary antiphospholipid syndrome and SLE: patterns of reactivity with membrane antigens on microvascular and umbilical venous cell membranesBritish Journal of Haematology, 1998
- Phospholipid Binding Plasma Proteins Required for Antiphospholipid Antibody Detection-An OverviewAmerican Journal of Reproductive Immunology, 1997
- Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndromeRheumatology, 1996
- Immunology of the antiphospholipid antibody syndromeArthritis & Rheumatism, 1996
- Antibodies to Phospholipid-Binding Plasma Proteins and Occurrence of Thrombosis in Patients with Systemic Lupus ErythematosusClinical Immunology and Immunopathology, 1996
- Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodiesBritish Journal of Haematology, 1991
- SYNDROME OF THE BLACK SWANRheumatology, 1987